DMLP:NASDAQDorchester Minerals, L.P. Analysis
Data as of 2026-03-29 - not real-time
$28.05
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Dorchester Minerals, L.P. is trading firmly above its short‑term moving averages with a bullish technical profile – the 20‑day SMA sits above the 50‑day and 200‑day averages, the MACD line is above its signal, and the RSI is hovering near the overbought region.
The stock offers an exceptionally high dividend yield that far exceeds the sector norm, yet the payout ratio is well above sustainable levels, raising questions about dividend continuity. Valuation metrics suggest a sizable discount to intrinsic value, with a discounted cash‑flow estimate markedly higher than the current market price, while the price‑to‑earnings ratio aligns closely with industry peers. Low beta points to muted market‑wide volatility, but recent price swings have been relatively pronounced, and the energy royalty business faces moderate regulatory and sector‑specific headwinds.
The stock offers an exceptionally high dividend yield that far exceeds the sector norm, yet the payout ratio is well above sustainable levels, raising questions about dividend continuity. Valuation metrics suggest a sizable discount to intrinsic value, with a discounted cash‑flow estimate markedly higher than the current market price, while the price‑to‑earnings ratio aligns closely with industry peers. Low beta points to muted market‑wide volatility, but recent price swings have been relatively pronounced, and the energy royalty business faces moderate regulatory and sector‑specific headwinds.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish momentum with MACD crossover
- Price holding above recent support
- Attractive entry relative to DCF valuation
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High dividend yield offset by sustainability concerns
- Stable cash flow from royalty assets
- Potential volatility from energy market cycles
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term undervaluation versus intrinsic value
- Low beta and defensive royalty business model
- Opportunity to capture upside if dividend policy improves
Key Metrics & Analysis
Financial Health
Revenue Growth9.70%
Profit Margin37.59%
P/E Ratio24.2
ROE17.20%
ROA10.60%
Debt/Equity0.26
P/B Ratio4.4
Op. Cash Flow$132.5M
Free Cash Flow$110.2M
Industry P/E24.0
Technical Analysis
TrendBullish
RSI69.8
Support$26.10
Resistance$28.33
MA 20$27.16
MA 50$25.78
MA 200$25.12
MACDBullish
VolumeStable
Fear & Greed Index65.98
Valuation
Fair Value$46.61
GradeUndervalued
TypeValue
Dividend Yield9.95%
Risk Assessment
Beta0.40
Volatility21.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.